Wichita Falls, Texas – GenBioPro, the manufacturer of generic mifepristone, which is approved by the U.S. Food and Drug Administration (FDA) as part of a two-drug regimen for the termination of early pregnancy, has filed a motion to intervene and a motion to dismiss in Florida et al. v. FDA in the U.S. District Court for the Northern District of Texas, Wichita Falls Division.
GenBioPro has moved to intervene due to the lawsuit’s attack on generic mifepristone and under the company’s belief that abortion medication is essential health care for millions across the nation.
“The relentless attacks on mifepristone’s FDA approval ignore decades of scientific evidence confirming the medication’s safety and efficacy, and disregard the millions of Americans who rely on it for essential care,” said GenBioPro CEO Evan Masingill. “Health care decisions belong with patients and their providers – not politicians. GenBioPro remains committed to using all legal and regulatory tools to protect access to mifepristone for millions of patients and providers across the country.”
The states of Florida and Texas’ complaint asks the court to entirely eliminate nationwide access to mifepristone by rolling back the FDA’s approval of mifepristone in 2000 and every decision FDA has made about mifepristone since, despite its overwhelming safety as demonstrated through decades of real world use, as well as a large body of scientific literature and evidence. Although the complaint was brought by the states of Florida and Texas, if these efforts succeed, all Americans would lose access to mifepristone.
GenBioPro is represented in the suit by Democracy Forward Foundation and Arnold & Porter.
“The lawsuit that Texas and Florida filed is just the latest in a series of copy-and-paste challenges designed to weaponize our court system and eliminate access to medication abortion that has long been proven safe,” said Skye Perryman, President and CEO of Democracy Forward. “Let’s be clear – these coordinated attacks on mifepristone attempt to impose an extreme political agenda that would never stand a chance in the democratic process, where an overwhelming majority of Americans support the legal right to abortion and evidence-based health care. Medication abortion has been a critical lifeline for millions of people. Democracy Forward will continue to use every legal tool available to protect access to evidence-based medical care, including medication abortion.”
GenBioPro was founded on the belief that all people – regardless of income, race, or geography – have a right to reproductive health care, including access to medical abortion. Consistent with that commitment, GenBioPro is promptly seeking to intervene in this litigation to ensure the defense of access to mifepristone for all.
GenBioPro’s motion to intervene in Florida et al. v FDA is here and the motion to dismiss is here.
– # # # –
Democracy Forward Foundation is a national legal organization that advances democracy and social progress through litigation, policy, public education, and regulatory engagement. For more information, please visit www.democracyforward.org.
